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Abstract 
Background 
Calpains are calcium regulated intracellular cysteine proteases implicated in a variety of 
physiological functions and pathological conditions. The Drosophila melanogaster genome 
contains only two genes, CalpA and CalpB coding for canonical, active calpain enzymes. The 
movement of the border cells in Drosophila egg chambers is a well characterized model of 
the eukaryotic cell migration. Using this genetically pliable model we can investigate the 
physiological role of calpains in cell motility. 
Results 
We demonstrate at the whole organism level that CalpB is implicated in cell migration, while 
the structurally related CalpA paralog can not fulfill the same function. The downregulation 
of the CalpB gene by mutations or RNA interference results in a delayed migration of the 
border cells in Drosophila egg chambers. This phenotype is significantly enhanced when the 
focal adhesion complex genes encoding for α-PS2 integrin (if), β-PS integrin (mys) and talin 
(rhea) are silenced. The reduction of CalpB activity diminishes the release of integrins from 
the rear end of the border cells. The delayed migration and the reduced integrin release 
phenotypes can be suppressed by expressing wild-type talin-head in the border cells but not 
talin-head
R367A, a mutant form which is not able to bind β-PS integrin. CalpB can cleave talin 
in vitro, and the two proteins coimmunoprecipitate from Drosophila extracts. 
Conclusions 
The physiological function of CalpB in border cell motility has been demonstrated in vivo. 
The genetic interaction between the CalpB and the if, mys, as well as rhea genes, the 
involvement of active talin head-domains in the process, and the fact that CalpB and talin 
interact with each other collectively suggest that the limited proteolytic cleavage of talin is 
one of the possible mechanisms through which CalpB regulates cell migration. 
Keywords 
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Background 
Calpains are intracellular cysteine proteases that are tightly regulated both temporally and 
spatially, as they require the binding of Ca
2+
 for their proteolytic function, and they are 
activated in a highly localized manner within the cells. Calpains are widespread and are 
implicated in a variety of physiological functions (signal transduction, cell motility, cell 
proliferation and differentiation, apoptosis, cell growth, cytoskeletal remodeling, membrane 
fusion) [1]. They are also associated with a diverse range of pathological conditions such as 
Alzheimer’s, Huntington’s and Parkinson’s diseases, multiple sclerosis, ischemic and 
traumatic brain injury, cancer, muscular dystrophy, cataracts, stroke and diabetes [2,3]. In 
mammals, they form a superfamily which is comprised of 15 cysteine protease catalytic 
subunits (including the homologue of Drosophila SOL), 2 regulatory subunits and the 
inhibitor, calpastatin. Some of the calpains are expressed ubiquitously, while others have a 
restricted tissue distribution [4]. 
The role of calpains in the migration of Chinese Hamster Ovary (CHO) cells was 
demonstrated with the aid of cell-permeable calpain inhibitors and a cell line expressing 
reduced level of Capn1 [5]. Both conditions leading to reduced calpain activity blocked cell 
migration at higher fibrinogen concentrations, inhibited the cell-substratum detachment at the 
trailing edge of the cells, and decreased the release of integrins from the cell membrane. 
From this data it was concluded, that calpain destabilizes the connection between the 
adhesion complexes and the cytoskeleton at the rear of the moving cells. Palecek et al. 
confirmed that a calpain inhibitor decreased integrin release behind the cells when the rear 
detachment was the rate limiting step of migration [6]. The downregulation of a mammalian 
Capn2 by RNA interference lead to similar results: the dissociation rate of adhesion 
complexes was decreased [7]. Moreover, when a calpain-resistant Talin1 was expressed in 
cells with Talin1 null background, the rate of disassembly of the focal adhesion complexes 
was also lower indicating that adhesion turnover was regulated by the Capn2-mediated 
cleavage of Talin1 [7]. In addition to talin calpain has a whole array of motility related 
substrates [4]. For example in the focal adhesion complexes two essential scaffolding 
molecules, focal adhesion kinase FAK [8] and paxillin [9] have been recently identified as 
physiological targets of calpain cleavage. Despite remarkable progress, our knowledge about 
the role of individual calpains during cell migration is incomplete due to the large number 
and variety of calpains as well as their potential substrate proteins. 
In contrast to mammals, the Drosophila genome contains only four genes encoding calpain-
related proteins. Out of these, only CalpA and CalpB encode canonical, active calpain 
enzymes. The CalpC gene product is an inactive protease, while CalpD (sol) encodes an 
atypical calpain molecule [10]. The structural characteristics of the Drosophila calpains are 
very similar to that of the mammalian enzymes, although they have two distinguishing 
features: the CalpA protein carries a 76 amino acid long hydrophobic insert in its C-terminal 
end, and the CalpB protein has an unusually long N-terminal tail of 224 amino acids. The 
exact molecular functions of these extra sequences are not known. There are two other 
distinctive enzymatic characteristics of the Drosophila calpains: they do not need small 
regulatory subunits for their catalytic activity, and their proteolytic function is not regulated 
by an intrinsic inhibitor as the Drosophila genome contains neither regulatory subunit nor 
calpastatin orthologs. In addition to the smaller number of calpain genes, Drosophila also 
offers a genetically well-tractable model system in which the functions of calpains and their 
molecular interactions can be studied at the organism level. 
Movement of the border cells in Drosophila egg chambers is a well characterized genetic 
model of the eukaryotic cell migration [11,12]. Using this model, here we demonstrate that 
CalpB but not the structurally related CalpA has an important modulator function during in 
vivo cell migration. Based on our molecular-genetic and biochemical results we suggest that 
one of the potential targets of the CalpB catalyzed limited proteolysis is talin, an important 
component of the focal adhesion complex. 
Results 
CalpA and CalpB are not essential genes in Drosophila melanogaster 
The Drosophila melanogaster genome contains two catalytically active canonical calpain 
genes: CalpA and CalpB, but little is known about their in vivo roles. To characterize their 
functions, we generated deletions disrupting each gene. For the CalpA, the P{SUPor-
P}CalpA
KG05080
 transposon, inserted 948 bp upstream from the CalpA translation initiation 
site, was mobilized to obtain imprecise excisions. A single line, CalpA
808
, carrying a 2490 bp 
deletion, was identified by PCR. Mapping the breakpoints by sequence analysis revealed that 
the deficiency removed not only the P element, but 459 bp from the CalpA gene including the 
first untranslated exon and a 1907 bp sequence from the adjacent hts gene (Figure 1A). In 
CalpA
808
 homozygous mutant flies, the CalpA mRNA and the CalpA protein were not 
detectable by RT-PCR and Western blot, respectively (data no shown). Homozygous 
CalpA
808
 flies are viable, displaying no external morphological phenotypes, but the females 
are completely sterile; they do not lay eggs. In their ovaries, egg chamber development is 
arrested at early stages, reminiscent of the egg chamber phenotype of the female sterile 
mutants of the hts gene (data not shown, [13]). This female sterility was complemented in the 
CalpA
808
/Df(2R)ED3716
CG2
 transheterozygotes. The 12.8 kb long Df(2R)ED3716
CG2
 
deficiency completely eliminates the Fak56D and the CalpA genes and 834 bp from the hts 
gene (Figure 1A) [14] . Both the CalpA
808
 and the Df(2R)ED3716
CG2
 deficiencies affect the 
regulatory sequences of the hts, which in CalpA
808
 results in female sterility. Presumably, 
Df(2R)ED3716
CG2
 can complement this phenotype because it removes a shorter segment of 
hts and it does not eliminate those regulatory sequences that are responsible for the female 
sterility. From these data, we concluded that the female sterility of CalpA
808
 originates from 
the hts gene. However, in a more detailed analysis, it appeared that in CalpA
808
/ 
Df(2R)ED3716
CG2
 transheterozygous ovaries 10% of the egg chambers display a mild 
dumpless phenotype (data not shown) indicating that the Df(2R)ED3716
CG2
 deficiency can 
only partially complement the female sterility in CalpA
808
. In the CalpA
808
/Df(2R)ED3716
CG2
 
transheterozygotes, similarly to the CalpA
808
 homozygotes, no mRNA and no CalpA protein 
were present (Figure 1B and C). Since CalpA
808
/Df(2R)ED3716
CG2
 flies are viable, CalpA 
can be considered a non-essential gene. 
Figure 1 Isolation of CalpA and CalpB alleles. (A) Genomic organization of the CalpA 
locus at cytological position 56D5. The position of the CalpA
KG05080
 P-element, inserted 948 
bp upstream from the CalpA translation initiation site, is indicated. The breakpoints and the 
sizes of the CalpA
808
 and the Df(2R)ED3716
CG2
 deficiencies are shown at the bottom. The 
boxes represent exons in the gene and in the primary transcripts. (B) RT-PCR detects CalpA 
mRNA in the w
1118
 control strain and in the P{SUPor-P}CalpA
KG05080
 insertion line but not in 
the CalpA
808
/Df(2R)ED3716
CG2
 transheterozygotes. Arrows indicate wild-type genomic and 
complementary DNA RT-PCR fragments. (C) Western blotting of adult whole fly extracts 
reveals CalpA protein in the w
1118
 control strain and in the P{SUPor-P}CalpA
KG05080
 insertion 
line but not in the CalpA
808
/Df(2R)ED3716
CG2
 transheterozygotes. The lower panel shows 
loading controls; the arrows mark the positions of CalpA and α-actin bands. (D) Genomic 
organization of the CalpB locus at cytological position 67D1. The location of the 
CalpB
EY08042
 P-element, inserted 175 bp upstream from CalpB ATG, is indicated. The 
breakpoints and the sizes of the CalpB
505
 and CalpB
361
 deficiencies are shown at the bottom 
together with the size of the CBG
26
 genomic DNA fragment used for the rescue of the mutant 
phenotypes. The boxes indicate the exons in the primary transcript. (E) RT-PCR reveals the 
presence of truncated CalpB mRNA in the CalpB
505
 and CalpB
361
 homozygotes. The 
calculated sizes of the PCR products are designated by the arrows on the right. (F) No CalpB-
specific signals can be detected in the extracts from adult CalpB
505
 homozygous mutants by 
Western blotting. The arrows denote the positions of the full length 110 kDa CalpB in the 
upper panel, and the α-actin loading control bands in the lower panel, respectively 
To generate mutations in the CalpB gene, the P{EPgy2}CalpB
EY08042
 P-element, inserted 175 
bp upstream from CalpB ATG, was mobilized. Several imprecise excision lines were 
recovered, and the breakpoints of two alleles (CalpB
361
 and CalpB
505
) were identified by 
sequencing: both of them disrupted the CalpB gene only (Figure 1D). The longer deficiency, 
CalpB
505
, removes the P-element and 1047 bp from the CalpB gene. As a result of this 
deletion, the CalpB
505
 allele lacks the first 873 bp of the coding sequences of the CalpB gene. 
CalpB
361
 encompasses a shorter, 922 bp deletion with an identical starting point. In both the 
CalpB
361
 and the CalpB
505
 homozygous flies, truncated mRNAs were detected by RT-PCR 
(Figure 1E), but no full length or truncated CalpB protein bands were discernible in CalpB
505
 
by immunoblots (Figure 1F). The CalpB
505
 deficiency, together with the other isolated 
deletion alleles (including CalpB
361
), is homozygous viable and fertile, displaying no visible 
external abnormalities indicating that CalpB, similarly to CalpA, is not an essential gene in 
Drosophila. To test the possible functional redundancy of the CalpA and the CalpB genes, a 
double mutant line (CalpA
808
/Df(2R)ED3716;CalpB
505
/CalpB
505
) was generated which was 
also fully viable and fertile demonstrating that the CalpA and CalpB genes do not fulfill any 
common essential functions. 
CalpB but not CalpA modulates border cell migration in egg chambers 
Since CalpB is not required for vital functions, we investigated whether the CalpB mutants 
display any other developmental perturbations. Previous studies revealed that the follicular 
cells of the Drosophila egg chambers are particularly enriched in CalpB protein, and the gene 
is also highly expressed in the migrating border cells [15], which originate from the follicular 
cells. Guided by this cellular localization and by the literature showing that calpains are 
involved in the regulation of mammalian cell motility, we examined whether the egg 
chambers from flies carrying CalpB mutations display any abnormalities in the migration of 
border cells. In wild-type egg chambers, the border cells usually reach the anterior end of the 
oocyte by stage 10, while in CalpB homozygous mutants a significant portion of the border 
cells (32-38%) do not complete their migration by this stage (Figure 2), indicating that the 
lack of CalpB delays but does not arrest border cell migration. The quantitative analysis of 
the data (Figure 3) revealed no significant difference between the P{EPgy2}CalpB
EY08042
 P-
element insertion line and the wild type. The extent of the delay in border cell migration was 
similar in the CalpB
505
 and the CalpB
361
 lines. In these mutants, the border cells migrated in 
the correct direction; no guidance defect was observed. In a CalpB
505
 hemizygote containing 
a large chromosomal deficiency (Df(3 L)AC1) that removes the entire CalpB gene, the border 
cell migration was also delayed, just as much as in the homozygotes. To verify that the 
disruption of the CalpB gene is responsible for the slow migration, the genomic rescue 
fragment of the CalpB gene, termed CBG
26
, was introduced into the CalpB
505
 mutant. The 
rescue fragment restored the wild-type phenotype proving that the lack of CalpB gene is 
indeed responsible for the less efficient border cell movement. 
Figure 2 CalpB mutation delays border cell migration. Confocal micrographs of (A) 
control (w
1118
) and (B) CalpB
505
/CalpB
505
 egg chambers at stage 10A are triple labeled with 
phalloidin-TRITC (red) for the actin network, with GFP (green) to show the slbo-Gal4 
expression patterns and with DAPI (blue) for nuclei. The nurse cells (nc) and the oocyte (o) 
are indicated in panel A. The arrowheads show the positions of the border cell clusters, and 
the bars represent 30 μm The percentage scale represent the relative distances on the 
migration path between the anterior ends of the egg chambers and the oocytes. Note that in 
the wild-type egg chamber, the border cell cluster is located dorsally 
Figure 3 Quantification of the border cell migration defects. The alterations of border 
cells movements caused by CalpB and CalpA mutations, by RNA interference, or by the 
overexpression of talin heads are analyzed as in Figure 2. Colored bars indicate the 
proportion of stage 10A egg chambers in which border cells migrate 0% (pink), 1-25% 
(purple), 26-50% (dark blue), 51-75% (light blue), 76-99% (green) and 100% (yellow) of the 
wild-type distance. Thus, the color scale shows the relative distance of posterior border cell 
movement. Note that in the w
1118
 control the majority of border cells travel the 100% distance 
to reach the oocyte by stage 10A, and the next category (76-99% range) represents only a 
relatively mild migration defect. The genotypes and the corresponding numbers of the egg 
chambers examined are displayed at the left and the right of the chart, respectively 
As CalpB mutations do not block border cell migration completely, the possibility emerged 
that the other calpain gene, i.e. CalpA, may also be involved in the process. To test this 
hypothesis, egg chambers from CalpA
808
/Df(2R)ED3716
CG2
 transheterozygous flies were 
investigated. Although CalpA protein is not expressed in these flies, the border cells migrate 
normally (Figure 3). Furthermore, the CalpA and CalpB double mutants display a phenotype 
characteristic of CalpB single mutant indicating that CalpA is not required for border cell 
migration. We confirmed these results by downregulating the expression of the CalpA and 
CalpB genes in the border cells via RNA interference. The slbo-Gal4 driver was used to 
induce CalpA or CalpB specific RNA interference. CalpA RNAi did not influence border cell 
migration, but CalpB RNAi resulted in a similar, delayed migration phenotype as observed in 
the CalpB mutant (Figure 3). Consistently with earlier reports [16,17] the slbo-Gal4 driver 
operated rather specifically, it induced GFP expression exclusively in border cells, posterior 
polar cells, and some follicular cells at the anterior side of the oocytes (Figure 2). 
Consequently, the RNA interference results not only confirm the mutant phenotype, but also 
reveal that CalpB is required only in the border cells (and not in nurse cells) in order to 
regulate their migration. 
CalpB interacts with the focal adhesion complex proteins 
To investigate if the reduced cell motility was related to the focal adhesion complex proteins 
we silenced the expression of the genes encoding Drosophila integrins and talin (Figure 3). 
As expected from the published data [17] the border cell specific silencing of the 
myospheroid (mys, β-PS integrin) gene by RNA interference slowed down migration. Similar 
results were obtained when the inflated (if, α-PS2 integrin) and the rhea (talin) genes were 
silenced: in all cases approx. 30% of the border cells were delayed. In the same RNA 
interference lines, border cell migration was normal when the slbo-Gal4 driver was absent 
indicating that the slower migration is due to the reduced expression of the affected genes. 
After establishing the phenotypes of the silenced lines we tested the genetic interrelationship 
between the focal adhesion protein coding genes and CalpB. The frequency and severity of 
the migration defect increased when the mys, if and rhea genes were downregulated in a 
homozygous CalpB
505
 background (Figure 3). RNA interference flies without the slbo-Gal4 
driver in the CalpB
505
 background showed the expected 30% mutant migration phenotype 
resulting from the deletion of the CalpB gene alone. Thus, our data provide genetic evidence 
for the functional interaction of CalpB with the mys, if, and rhea genes. 
It is known, that the migration of the border cells takes place in two phases: first they proceed 
posteriorly from the anterior end of the egg chamber, then, after reaching the oocyte, they 
move towards the dorsal side, and by stage 10B they are positioned next to the germinal 
vesicle. The analysis of the second stage of migration is of interest, since some mutations, 
like gurken influence specifically the dorsal movement of the border cells with little effect on 
the initial posterior migration [18]. By investigating the egg chambers at stage 10B, we found 
that a significant portion of the border cells (46%) in the CalpB
505
 mutants displayed a delay 
in the dorsal movement (Additional file 1). The dorsal migration of the border cells was even 
more severely delayed when the mys, if, and rhea genes were silenced by RNA interference 
in the CalpB
505
 mutants: at stage 10B most of the cells (92.0%, 73.7%, and 83.6%, 
respectively) remained at the midline of the egg chambers. Our data collectively indicate that 
the CalpB gene is involved both in the posterior and in the dorsal migration of the border 
cells and interacts with the cell adhesion genes mys, if, and rhea. 
Since in cultured cells the reduction of calpain activity not only delayed motility but also 
reduced the amount of integrins released from the trailing cell membrane [6] we analyzed the 
role of CalpB in this process under in vivo conditions (Figure 4). The egg chambers were 
stained for β-PS integrin and the released integrins were visualized as discrete spots behind 
the border cells in the anterior part of the wild-type egg chambers (Figure 4A). In the 
CalpB
505
 mutant, the number of the β-PS integrin-containing spots was significantly reduced 
(Figure 4B). The downregulation of the CalpB gene by RNA interference had the same effect 
as the CalpB
505
 deletion: in the control slbo-Gal4 driver strain the number of the released β-
PS integrin spots was similar to that of the wild type (Figure 4C) while in the slbo-Gal4 
>CalpB RNAi silenced strain this number was close to that of the CalpB
505
 mutant (Figure 
4D). Thus, CalpB modulates integrin function in vivo in the border cells during their 
migration. As we found that the downregulation of the talin-encoding gene, rhea, also had a 
delaying effect on border cell migration, and this effect was aggravated in a CalpB
505
 
background (Figure 3), we investigated the effects of the same conditions on integrin release. 
The silencing of rhea alone in the border cells decreased integrin release to about 60% of the 
wild-type level (Figure 4E) while, the integrin spots were hardly detectable when rhea was 
silenced in the CalpB
505
 mutant background (Figure 4F). Our data lend additional support for 
the interaction between rhea and CalpB, but at the same time indicate that CalpB must act via 
additional targets, since the talin silencing phenotype (Figure 4E) is significantly weaker than 
the calpain knockdown or deletion phenotypes (Figure 4D and 4B). 
Figure 4 Quantification of integrins released from the border cells during migration. In 
the confocal micrographs of (A) wild-type (w
1118
), (B) CalpB
505
, (C) slbo-Gal4, (D) slbo-
Gal4 >UAS-CalpBRNAi, (E) slbo-Gal4 >UAS-rheaRNAi, (F) slbo-Gal4 >UAS-rheaRNAi; 
CalpB
505
 egg chambers, the areas of egg chambers around and behind the border cells are 
labeled with phalloidin-TRITC (red) for actin, with anti-β-PS integrin (green), and with DAPI 
(blue) for nuclei. In the inserts, the area directly behind the border cells is magnified. The 
movement of the border cells proceeds from the left to the right, and the released integrins 
left behind the cells appear as discrete spots (labeled by arrowheads) at the left sides of the 
images. Representative pictures of 20–23 independent experiments are shown. The calculated 
average numbers of integrin spots at the rear of the border cells per egg chamber, and the 
corresponding number of investigated egg chambers (n) are indicated by the diagrams at the 
right side of each panel. Note that only the spots falling into the cells’ pathway were scored, 
and groups of closely situated spots were counted as a single “spot”. Bars indicate 100 μm 
Functionally competent talin head-domain abrogates the effects of CalpB 
mutation 
To dissect the nature of the CalpB-rhea interaction we utilized a construct that overexpresses 
the globular head domain of talin, which can bind to and activate integrins. In a wild-type 
genetic background, the expression of a Talin head-GFP fusion polypeptide in the border 
cells did not significantly alter the migration of the border cells, but restored the normal 
migration rate in CalpB
505
 mutant egg chambers (Figure 3). In addition, the expression of a 
mutant (R367A) Talin head-GFP [19], which is unable to bind β-PS integrin (and activate the 
integrin dimer), had no effect on the migration delay of the CalpB
505
 border cells (Figure 3). 
In correlation with the above results, we found that the amount of integrins released at the 
rear of the border cells was normal when the wild-type Talin head-GFP was expressed in the 
border cells (Figure 5A), in CalpB
505
 mutant border cells Talin head-GFP expression 
elevated integrin release to the wild-type level (Figure 5B vs. 5C), while the Talin head
R367A
-
GFP expression had no effect on the CalpB
505
 mutant phenotype (Figure 5D). With these 
experiments, we demonstrated that overexpression of a functionally competent Talin head 
suppresses the characteristic phenotypes of the CalpB mutant border cells, suggesting that 
CalpB mediates cell migration via the proteolytic release of the head region from talin. 
Figure 5 Effect of talin head domain overexpression on integrin release from border 
cells. In the confocal images of (A) slbo-Gal4 >UAS-TalinH-GFP, (B) slbo-Gal4;CalpB
505
, 
(C) slbo-Gal4 >UAS-TalinH-GFP; CalpB
505
 and (D) slbo-Gal4 >UAS-TalinH
R367A
-GFP; 
CalpB
505
 egg chambers, integrins were stained with Alexa-546 conjugate (red), TalinH-GFP 
fusion proteins were visualized in green and the nuclei were labeled with DAPI (blue). The 
images were analyzed as described in Figure 4. Bars represent 100 μm 
Calpain directly interacts with talin 
To verify that Drosophila talin can act as an in vitro substrate of CalpB, embryonic extracts 
were incubated with purified recombinant CalpB. In the presence of Ca
2+
, the cleavage of the 
full length talin was complete within 5 minutes, whereas in the presence of the Ca
2+
 chelator 
(EDTA) the full length talin band remained intact (Figure 6A). It should be noted, that the 
recombinant protease required rather high Ca
2+
 concentration for activation, but in the in vitro 
tests of calpain activity it is commonplace to use the metal ion in the non-physiological mM 
range [20]. The physical interaction between talin and CalpB was shown by co-
immunoprecipitation (Figure 6B). After the incubation of embryonic extracts with anti-talin 
antibody, CalpB was detected in the precipitate. As talin is a potential substrate of CalpB, and 
the two proteins make a physical contact with each other, it is feasible to assume that CalpB 
may function via talin scission in the modulation of cell migration. However, we also noted 
that talin was partially degraded in an untreated CalpB
505
 embryo extract (Figure 6A), clearly 
showing that in the absence of CalpB other proteases can digest talin, even if Ca
2+
 was not 
added. 
Figure 6 Physical interaction between CalpB and talin in Drosophila. (A) Talin is an in 
vitro substrate of CalpB. Crude protein extracts of stage 2 embryos were analyzed directly 
(0’) or were treated with recombinant CalpB for 5 minutes (5’) in the absence and presence of 
20 mM Ca
2+
 or 10 mM EDTA. An untreated extract from CalpB
505
 embryos was also tested 
for comparison. The proteolytic fragmentation of talin was investigated by Western blotting 
using a talin-specific antibody (upper section). The loading of the lanes was tested by a 
tubulin-specific antibody (lower section). St denotes molecular mass standards; the positions 
of two pre-stained bands are labeled at the left side, and arrows indicate the main 
immunoreactive talin bands at the right side. (B) Coimmunoprecipitation of talin with CalpB. 
Immunoprecipitations were performed in embryonic extracts with anti-Talin antibody, and 
the immunoblots were stained with anti-CalpB antibody. The positions of the full-length 
CalpB bands are marked by the arrow 
Discussion 
Comparison of calpain functions in mammals and Drosophila 
The analysis of CalpA
808
/Df(2R)ED3716
CG2
 hemizygotes and CalpB
505
 homozygous mutants 
clearly shows that both CalpA and CalpB are dispensable for viability and fertility while the 
features of the CalpA and CalpB double mutant prove that they do not share vital functions 
during Drosophila development. These findings were unexpected since earlier experiments 
with the mammalian Capn4 gene (encoding a small calpain regulatory subunit) suggested that 
calpains are required for normal development in mice [21,22]. Since the lack of Capn4 can 
affect both the Capn1 and Capn2 activities, these proteases were investigated separately by 
knocking out their corresponding genes. The elimination of Capn2 resulted in early 
embryonic lethality [23], while the disruption of Capn1 did not affect viability [24] indicating 
that from the two ubiquitous calpain genes only one (Capn2) is indispensable. Although the 
loss-of-function mutation of the Capn1 gene did not influence viability and fertility, it 
affected platelet aggregation and clot retraction [24]. Similarly, disruption of the Capn3 gene 
has no lethal consequences; the life span of the mutant was normal, but a moderate loss of 
sarcolemmal integrity could be detected in the KO mice [25]. Thus, the mammalian Capn1 
and Capn3 genes are not essential, but play important modulator roles during development. 
Similarly, we observed that the CalpB gene in Drosophila is not required for essential 
physiological functions, but has a modifying role in border cell migration. 
Although the CalpA protein is expressed in all stages of Drosophila development (Additional 
file 2) the CalpA gene is also dispensable for viability and fertility. It should be noted that our 
results do not confirm the conclusions of a recent paper [26] reporting that the 
downregulation of CalpA by the microinjection of double stranded RNAs resulted in the 
dorsalization of embryos: a significant portion of the larvae did not hatch and bore cuticule 
defects. In our case, the larvae of CalpA
808
/Df(2R)ED3716
CG2
 transheterozygotes displayed 
no visible dorsoventral patterning abnormalities and exhibited no cuticular defects (data not 
shown). They hatched, although the hatching rate of the embryos was somewhat lower than 
the theoretical ratio owing to dumpless eggs (10%) which did not hatch. Fontenele et al. [26] 
also reported that the downregulation of CalpB by RNA interference has similar dorsalization 
effects with very low hatching rate and cuticle defects. However, the embryonic development 
of our CalpB mutants was normal without any reduction in hatching (data not shown). The 
discrepancy may be related to the utilization of different genetic tools; we suppose that the 
developmental defects [26] may have been generated by some off-target effects of the 
microinjection based silencing approach. Since both CalpA
808
 and CalpB
505
 are protein null 
alleles, it is likely that neither CalpA nor CalpB are involved in the establishment of the 
dorsoventral axis in Drosophila. Nevertheless, the Drosophila calpains may have modulator 
roles in other cellular processes like cell migration, neuronal functions or phagocytosis. 
Indeed it has been shown recently that the downregulation of CalpA by RNA interference 
significantly decreases the S2 cell phagocytosis of C. albicans [27], and that CalpB can 
modify the effect of the human leukemogenic fusion protein AML1-ETO when expressed in 
Drosophila blood cells [28]. 
In vivo evidence for the involvement of CalpB in cell migration 
Here we provide the first in vivo evidence showing that calpains modulate cell motility at the 
whole organism level. In CalpB mutant egg chambers, border cells display a moderate delay 
during migration. In our study, we were also able to detect released β-PS integrin behind the 
border cells in wild-type egg chambers. In the absence of CalpB, the released β-PS integrin 
was markedly reduced in the egg chambers that displayed delayed migration. These results 
are in correlation with previous data obtained with a mammalian cell line showing that the 
inhibition of calpain activity decreased the rear detachment rate and gave rise to less integrins 
to be released from the rear of migrating cells [6]. We also noticed that the effects of CalpB 
insufficiency on cell motility were synergistically enhanced when the expression of integrins 
and talin, the components of the focal adhesion complex, were silenced. However, our data 
are at variance with an earlier paper [29] reporting that the knocking down of talin has no 
effect on border cell migration. This discrepancy is especially disturbing since our RNA 
interference construct originates from the same source (6831R-2, NIG-FLY). The only 
difference between the two experimental conditions was that we performed the silencing at 
30°C while Llense and Martin-Blanco [29] did it at 25°C. To test the importance of the 
cultivation conditions, we carried out the same RNA interference experiments at both 
temperatures. At 30°C, the penetrance was 29%, while in parallel experiments carried out at 
25°C it was only 18% (Additional file 3). We conclude that the phenotype exists at both 
temperatures but can be more readily detected and characterized at 30°C. Since Llense and 
Martin-Blanco [29] used a less graded scoring scale than we, it is possible, that they counted 
the small migration defect as normal. Indeed, the migration phenotypes of the single rhea and 
CalpB knockdown strains are mild but the combination of them results in a strong effect that 
reveals the role of both genes in border cell migration. Thus we are convinced that the genetic 
interaction between CalpB and the focal adhesion protein coding mys, if and rhea is a solid 
fact that we substantiated by two independent methods. We also fund that the above 
interaction is important for both the posterior and dorsal components of the border cell 
migration, thus it affects a general aspect of cell motility. 
It is more difficult to ascertain the molecular mechanisms underlying the above interactions, 
because the proteins that we manipulated by molecular genetic methods are members of a 
large complex characterized by a complicated network of direct and indirect, molecular and 
functional, interactions. Although we demonstrated that Drosophila talin is an in vitro 
substrate of CalpB, and the two proteins are in physical contact with each other in embryo 
extracts we do not have direct evidence for a talin cleavage mediated calpain action in the 
border cells. We cannot exclude the possibility that the protease acts in talin independent 
pathways as well, for example via the limited proteolysis of FAK [8], paxillin [9] or other [4] 
potential substrates that affect cell motility. In fact, our integrin release tests show that the 
effect of talin silencing is less pronounced than the effects of CalpB silencing or deletion 
(Figure 4) suggesting that besides talin other calpain targets must be involved in the process. 
Furthermore, we found that in the CalpB
505
 null mutant flies other unidentified proteases can 
also recognize talin as a substrate (Figure 6A). Disregarding the uncertainty of the exact 
mechanisms our finding that the overexpression of a Talin head-GFP construct can suppress 
both the delayed migration and the reduced release of integrins at the rear in CalpB
505
 border 
cells is intriguing, especially because only the functionally competent talin head domain was 
effective, the mutant variant that is unable to bind integrins had no effect. Thus calpain B 
action and the activation of integrins by the active talin head domains are functionally related 
events. Based on circumstantial evidence and analogies with the cell line experiments [7] it is 
tempting to speculate that CalpB generates talin heads that activate integrin clustering, and at 
the same time CalpB weakens the connection between integrin and the extracellular matrix at 
the trailing end of the cells by cleaving additional protein substrates [6]. In these ways calpain 
B may contribute to the tension generation and the ripping off of the integrins at the rear of 
the border cells and acts as a regulator of cell migration in the Drosophila ovaries. 
Conclusions 
We demonstrated at the organism level that the canonical calpains in Drosophila, CalpA and 
CalpB, are dispensable for vital functions, but CalpB has a modulator role in the regulation of 
cell migration: it fine-tunes the adhesion complexes in the border cells during their migration. 
It is interesting to note that among the 18 mammalian calpain superfamily members, only 
Capn1 and Capn2 are involved in the regulation of cell motility [30], but only Capn2 can 
cleave talin in vivo. In an analogous way, only one of the two canonical Drosophila calpain 
genes, CalpB, is implicated in border cell migration, and may act via the digestion of talin. 
Thus one of the important calpain functions was most probably conserved between mammals 
and Drosophila. 
Cell motility is an essential factor governing development [31]. The uncovering of the role of 
CalpB and the functionally competent talin head in border cell migration supports existing 
models and helps the better understanding of cell motility in general. Besides cell adhesion, 
cell spreading and cell protrusion formation are important developmental processes in which 
the role of CalpB remains to be elucidated. 
Methods 
Fly stocks 
Unless indicated otherwise, all Drosophila stocks were maintained and crossed at 25°C 
according to standard procedures. Since the efficiency of the genes silencing was found to be 
temperature dependent [32], RNA interference experiments were carried out at 30°C. P-
element insertion lines, Df(3 L)AC1) and slbo-Gal4 >UAS-GFP were obtained from the 
Bloomington Stock Center, slbo
1310
slbo-Gal4 from P. Rorth, Df(2R)ED3 from R. Palmer and 
UAS-TalinH-GFP and UAS-TalinH
R376A
-GFP from N. Brown. RNA-interference 
transformants for CalpB (ID: 23037) and CalpA (ID: 35262) were purchased from VDRC, 
Austria, and for if (ID: 9623R-2), mys (ID: 1560R-1) and rhea (ID: 6831R-2) from NIG-
FLY, Japan. We regret to note that the CalpA and CalpB deletion alleles, which were 
specifically generated during the course of our studies for the investigations of calpain 
functions, were unfortunately lost after the unexpected death of the GÁ, and cannot be 
supplied to the scientific community. 
Nucleic acid isolation and amplification 
Genomic DNA was isolated from single flies according to [33]. Total RNA was isolated with 
Trizol Reagent (Invitrogen) according to [34] and was treated with RNase-free DNase 
(Promega). RT-PCR was carried out as described in [35] with the CalpA_For, CalpA_Rev, 
and CalpB_For, CalpB_Rev oligonucleotide primer pairs. Primers 5CB1 and 3CB2 were 
used to PCR amplify the CalpB gene fragments from the deletion mutants. These fragments 
(approx. 1300 bp from Calp
361
 and 1150 bp from CalpB
505
) were isolated from agarose gels 
with the QIAGEN Gel Extraction Kit, and were sequenced subsequently in order to delineate 
the chromosomal breakpoints in the mutants. The breakpoints in the CalpA
808
 deletion mutant 
were determined in the same way, but with the 5HH and CP2 primers that produced a 7324 
bp amplicon. The PCR analysis of the CalpB
505
, UAS-TalinH-GFP recombinant lines were 
performed with the 5CB1 and 3CB2 primers. Oligonucleotide primers and PCR conditions 
used in the present study are summarized in Additional file 4. 
DNA cloning and transformation 
The CalpB genomic sequence was excised from the BAC RP98-7A5 vector (Roswell Park 
Cancer Institute Drosophila BAC Library) with XbaI (Fermentas). The approximately 6kbp 
fragment was isolated and inserted into the Bluescript II KS plasmid. Then the CalpB gene 
was released with EcoRI and XhoI (Fermentas) restriction enzymes and was ligated into the 
pP{CaSpeR-4} transforming vector. This construct (termed CBG
26
) that contains the entire 
ORF as well as 5’- and 3’-noncoding sequences (Figure 1D) was injected into the embryos 
according to standard procedures. 
Immunohistochemistry 
Before dissection, females were fed for 24 hours with wet yeast paste at 25°C (at 30°C in 
RNA interference experiments), and ovaries were dissected in PBS buffer, fixed with 4% 
paraformaldehyde, washed 3x with PBS and 0.1% Triton-X100. Immunostainings were 
performed as described earlier [36]. Anti-β-PS integrin monoclonal antibody was obtained 
from DSHB and was diluted 1:10. As secondary antibodies, Alexa-488 and Alexa-546 
conjugates (Invitrogen) were used in 1:500 dilutions. The actin cytoskeleton and the nuclei 
were stained with TRITC-Phalloidin (Sigma-Aldrich) and DAPI (Sigma-Aldrich), 
respectively. Examination and counting of the samples were conducted using an Olympus 
FV1000 LSM confocal laser scanning microscope. Images were obtained by combining 
multiple optical sections using the Olympus Fluoview Ver.1.7a Viewer software’s “intensity 
projection over z-axis” function. Figures were prepared with the Adobe Photoshop CS4 
software. 
Western blotting 
Western blot experiments were carried out according to [37]. Crude extracts (25 μg protein) 
representing different developmental stages of Drosophila w
1118
 strain were separated by 
SDS-PAGE [38]. Recombinant CalpB and CalpA were used as positive controls. Anti-CalpB 
and Anti-CalpA polyclonal antisera were generated against the full length recombinant 
proteins according to [15] and [39], respectively. Anti-Talin antibody was kindly provided by 
Nicholas Brown (Wellcome Trust/Cancer Research UK Institute, Department of Anatomy, 
University of Cambridge, Cambridge, UK). In embryo samples anti-β-Tubulin monoclonal 
antibody (Millipore/Upstate clone DM1A), while in other developmental stages anti-Actin 
polyclonal antibody (Sigma-Aldrich 20–33) were used to detect internal standards. Anti-
CalpB and anti-Talin antibodies were used in 1:1000 dilution; anti-CalpA, anti-Actin and 
anti-Tubulin antibodies were applied in 1:2000 dilution. Anti-CalpB, anti-CalpA and anti-
Actin antibodies were visualized with horseradish peroxidase conjugated anti-rabbit IgG 
raised in goat (Sigma-Aldrich A0545); the anti-Talin and anti-Tubulin antibodies were 
revealed with anti-mouse IgG secondary antibodies raised in rabbit (Sigma-Aldrich A9044). 
Secondary antibodies were diluted 1:10.000 in all of the experiments. A mixture of high and 
low molecular weight standards (Sigma-Aldrich), or Spectra Multicolor Broad Range and 
PageRuler (Fermentas) prestained protein ladder were used as molecular mass markers. 
Horseradish peroxidase activity was detected with Supersignal West Pico chemiluminescent 
reagent (Pierce) and the emitted light was captured by blue sensitive X-ray film (Agfa). 
Immunoprecipitation 
20 adult flies of the Drosophila w
1118
 strain were ground and lysed in 200 μl lysis buffer (50 
mM Tris, pH:7.5, 150 mM NaCl, 10 mM EDTA, 0.1% Triton X-100, 0.01% β-
mercaptoethanol and 1xRoche Complete EDTA-free Protease Inhibitor Cocktail). Further 
steps of the immunoprecipitation were carried out according to [20] with the following 
modifications: the supernatants were immunoprecipitated with 40 μg of talin antibody 
adsorbed to Protein A Sepharose (Sigma-Aldrich). The immunocomplex was analyzed by 
Western blotting 
In vitro cleavage of Drosophila talin with recombinant CalpB 
100 mg of stage 2 Drosophila embryos were homogenized in 100 μl lysis buffer (50 mM 
Tris–HCl, pH 7.5, 150 mM NaCl, 2 mM dithiothreitol and 10 mM NaF) in ice. Cell debris 
were removed by centrifugation (2 min, 2000 g at 4°C) and the clear supernatant was treated 
with recombinant Drosophila CalpB that was prepared and assayed as described in [20]. The 
reaction was carried out in the absence and presence of 20 mM Ca
2+
 or 10 mM EDTA for 5 
minutes at 25°C. The reaction was started by the addition of 1.5 μg CalpB enzyme and was 
terminated by the addition of SDS sample buffer containing 25 mM EDTA. Samples 
containing 3.2 μg proteins were boiled for 5 min in the presence of a pinch of dithioerytriol 
(Sigma-Aldrich) and were analyzed by Western blotting. 
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Additional files 
Additional_file_1 as PDF 
Additional file 1 Quantification of dorsal migration defects due to the CalpB
505
 mutation 
and to the downregulation of mys, if and rhea genes. Colored bars represent the percentage 
of stage 10B egg chambers in which border cells displayed normal (yellow) and delayed 
(green) dorsal migration. Only the dorsal component of the movement was scored in all 
samples. The genotypes and the corresponding numbers of the egg chambers examined are 
indicated at the left and the right sides of the chart, respectively. 
Additional_file_2 as PDF 
Additional file 2 Western blot analysis of CalpA expression in different developmental 
stages of Drosophila. Extracts prepared from early (stage 2) and late (stage 17) embryos (A), 
1
st
 ,2
nd
 and 3
rd
 instar larvae, pupae, as well as from adult male and female flies (B), were 
separated by SDS-PAGE and probed with anti-CalpA antibody. 20 ng recombinant CalpA 
was loaded in the control lane. The positions of the molecular mass standards are denoted. 
Arrows indicate the main protein bands stained with the CalpA-specific antibody. The 
positions of internal standards α-tubulin in panel A and α-actin in panel B are also indicated 
by arrows. 
Additional_file_3 as PDF 
Additional file 3 Temperature dependence of the rhea RNAi effect. The diagram displays 
the quantification of border cell migration delays caused by the silencing of the rhea gene at 
25°C and 30°C. Colored bars represent the proportion of stage 10A egg chambers in which 
border cells migrate 0% (pink), 1-25% (purple), 26-50% (dark blue), 51-75% (light blue), 75-
99% (green) and 100% (yellow) of the wild-type distance. The genotypes and the 
corresponding numbers of the egg chambers examined are represented at the left and the right 
of the chart, respectively. 
Additional_file_4 as PDF 
Additional file 4 Oligonucleotide primers and conditions used for PCR amplifications 
(PDF 16 kb) 
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